Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer
CompletedOBSERVATIONAL
Enrollment
69
Participants
Timeline
Start Date
April 30, 2005
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
Conditions
Metastatic Breast Cancer
Trial Locations (1)
48109
University of Michigan Cancer Center, Ann Arbor
All Listed Sponsors
lead
University of Michigan Rogel Cancer Center
OTHER
NCT00156273 - Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter